The search results do not contain any information confirming that 12 Ayurvedic formulations developed by CSIR have met WHO efficacy standards. While several CSIR-affiliated institutions, such as CSIR-NIIST, are involved in establishing centers of excellence in Ayurveda and conducting research on Ayurvedic formulations, no specific mention is made of 12 formulations meeting WHO efficacy benchmarks.
However, research conducted by CSIR-Central Institute of Medicinal and Aromatic Plants (CIMAP) and other bodies, in collaboration with institutions like King George’s Medical University, has focused on the standardization, formulation, and evaluation of Ayurvedic polyherbal formulations—such as Diabcap—into modern dosage forms like capsules, with an emphasis on quality control, safety, and pharmacological validation.
For example:
- A study on a polyherbal formulation (Diabcap) standardized using WHO guidelines and formulated into capsules demonstrated good antihyperglycaemic activity and favorable dissolution profiles.
- CCRAS (Central Council for Research in Ayurvedic Sciences)Â has developed comprehensive guidelines for drug development, safety evaluation, and clinical assessment of Ayurvedic formulations, aligning with international standards.Â
While these efforts reflect a move toward scientific validation and standardization of Ayurvedic medicines, the claim of 12 formulations meeting WHO efficacy standards is not supported by the provided search results.
